To include your compound in the COVID-19 Resource Center, submit it here.

MultiStem: Phase II started

Pfizer and Athersys began a double-blind, placebo-controlled, international Phase II trial to evaluate MultiStem in up to about

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE